AYTU BIOPHARMA, INC Class of Warrant or Right, Outstanding
AYTU BIOPHARMA, INC (AYTU) had Class of Warrant or Right, Outstanding of 12.63 million shares as of 2026-06-30, per its 10-K filed 2026-09-22.
Financial Statements › Notes › Other Liabilities
us-gaap:ClassOfWarrantOrRightOutstanding · last filed 2026-09-22
- 2026-06-30: Class of Warrant or Right, Outstanding 12.63M shares.
- 2026-03-31: Class of Warrant or Right, Outstanding 12.63M shares.
- 2025-12-31: Class of Warrant or Right, Outstanding 12.63M shares.
- 2025-09-30: Class of Warrant or Right, Outstanding 13.20M shares.
| Period end | Class of Warrant or Right, Outstanding | Class of Warrant or Right, Outstanding as first filed |
|---|---|---|
| 2026-06-30 | 12.63M shares 10-K · filed 2026-09-22 | |
| 2026-03-31 | 12.63M shares 10-Q · filed 2026-05-13 | |
| 2025-12-31 | 12.63M shares 10-Q · filed 2026-02-03 | |
| 2025-09-30 | 13.20M shares 10-Q · filed 2025-11-13 | |
| 2025-06-30 | 14.13M shares 10-K · filed 2025-09-23 | |
| 2025-03-31 | 5.90M shares 10-Q · filed 2025-05-14 | |
| 2024-12-31 | 5.90M shares 10-Q · filed 2025-02-12 | |
| 2024-09-30 | 5.90M shares 10-Q · filed 2024-11-13 | |
| 2024-06-30 | 6.08M shares 10-Q · filed 2025-05-14 | |
| 2024-03-31 | 6.48M shares 10-Q · filed 2024-05-15 | |
| 2023-12-31 | 6.48M shares 10-Q · filed 2024-02-14 | |
| 2023-06-30 | 6.54M shares 10-K · filed 2024-09-26 | |
| 2021-03-31 | 1.26M shares 10-Q · filed 2021-05-17 | |
| 2020-12-31 | 2.69M shares 10-Q · filed 2021-02-11 | |
| 2020-06-30 | 2.29M shares 10-Q · filed 2021-05-17 | |
| 2018-03-31 | 47.00K shares 10-Q · filed 2018-05-14 | |
| 2017-02-28 | 25.54K shares 10-K · filed 2017-08-31 | 510.82K shares 10-Q · filed 2017-05-11 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| NextCure, Inc. (NXTC) | United States | $0.024B | -0.15 |
| TherapeuticsMD, Inc. (TXMD) | United States | $0.024B | -117.87 |
| ARTELO BIOSCIENCES, INC. (ARTL) | United States | $0.023B | |
| KYNTRA BIO, INC. (KYNB) | United States | $0.028B | 0.17 |
| Transcode Therapeutics, Inc. (RNAZ) | United States | $0.029B | -0.12 |
| Cocrystal Pharma, Inc. (COCP) | United States | $0.022B | |
| Hepion Pharmaceuticals, Inc. (HEPA) | United States | $0.029B | -0.62 |
| ATOSSA THERAPEUTICS, INC. (ATOS) | United States | $0.021B | -0.52 |
| IGC Pharma, Inc. (IGC) | United States | $0.029B | -5.98 |
| Neuphoria Therapeutics Inc. (NEUP) | United States | $0.020B | -1.77 |